Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
Ridker PM, Bhatt DL, Pradhan AD, et al.
Lancet. 2023;S0140-6736(23)00215-5.
Leggi
Breaking news
Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes – a randomized clinical trial
Pagidipati NJ, Nelson AJ, Kaltenbach LA, et al.
JAMA. 2023;e232854.
Leggi
Standards of care for the health of transgender and gender diverse people, version 8
Coleman E, Radix AE, Bouman WP, et al.
Int J Transgend Health. 2022;23(Suppl 1):S1-S259.
Leggi
OZEMPIC: STATO DI CARENZA
6/03/2023
Leggi
Association of long‐term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study
Yu JH, Kim REY, Park SY, et al.
Diabetes Obes Metab. 2023;25(4):1091-1100.
Leggi
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS‐1 to ‐5 studies
Lingvay I, Cheng AYY, Levine JÁ, et al.
Diabetes Obes Metab. 2023;25(4):965-974.
Leggi
Distinct mechanisms responsible for the increase in glucose production and ketone formation caused by empagliflozin in T2DM patients
Abdelgani S, Khatab A, Adams J, et al.
Diabetes Care. 2023;dc220885.
Leggi
Interaction between dietary iron intake and genetically determined iron overload: risk of islet autoimmunity and progression to type 1 diabetes in the TEDDY study
Thorsen SU, Liu X, Kataria Y, et al.
Diabetes Care. 2023;dc221359.
Leggi
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial
Pigeyre M, Gerstein H, Ahlqvist E, et al.
Diabetologia. Pub. online 1 Mar 2023.
Leggi
Prevalence of QT prolongation and its risk factors in patients with type 2 diabetes
Aburisheh K, AlKheraiji MF, Alwalan SI, et al.
BMC Endocr Disord. 2023;23(1):50.
Leggi